Search NLS News

Karolinska University Hospital’s director Björn Zoëga and Karolinska Institute’s rector Annika Östman Wernerson have signed an agreement to establish a new joint center for advanced cell, gene and tissue therapies. The new center, which has operations both in Huddinge/Flemingsberg and in Solna, will be named Karolinska ATMP-centrum. ATMP stands for Advanced Therapy Medicinal Products. “Already […]

Guard Therapeutics has announced top-line results from its AKITA study, evaluating RMC-035 for the prevention of kidney injury in open-heart surgery. Patient recruitment was prematurely stopped, and as expected the primary (short-term) endpoint, incidence of acute kidney injury (AKI) within 72 hours after surgery, was not reached, describe sthe company. “Importantly though, pre-defined secondary endpoints […]

The 2023 Ig Nobel Prizes celebrates for example backward reading and counting nostril hairs. The 2023 Ig Nobel Prizes were awarded at the 33rd First Annual Ig Nobel Prize ceremony, September 14, 2023. The Prizes honor achievements that make people laugh, then think, and they are intended to celebrate the unusual, honor the imaginative — […]

Evaxion Biotech has initiated a novel pipeline program, EVX-B3, an AI-designed vaccine candidate against an undisclosed bacterial pathogen. The new vaccine project will be a collaboration between Evaxion and an undisclosed leading pharmaceutical company, leveraging unique assets and know-how from both organizations, states the company A collaborative and co-funded effort To develop an effective vaccine, […]

Orexo has announced the submission of the New Drug Application (NDA) to the US Food and Drug Administration for OX124, a high-dose rescue medication for opioid overdose with nasal delivery. OX124, is based on Orexo’s drug delivery platform amorphOX and is designed to reverse the effects of the most powerful synthetic opioids, such as fentanyl. […]

In June 2023, the Swedish Presidency of the Council of the European Union called for reinforcing, accelerating, and maximizing the benefits of fair and open research data in Europe, within scientific communities and through research infrastructures, to increase the overall research and innovation performance in Europe and strengthen the outreach to and impact on industry […]

The aim of the research collaboration is to reveal the mechanism of action and pharmacological characterization of a drug candidate. Under the terms of the collaboration, Salipro Biotech will utilize its expertise in stabilizing challenging membrane proteins such as GPCRs, ion channels and transporters via its Salipro technology platform to advance a Sumitomo Pharma’s drug […]

With the investment, Lauxera Capital Partners is joining with other investors, majority owner Bure Equity AB and Northislet AB, as well as with BioLamina’s founders and executives as shareholders in support of the company’s mission. “The BioLamina team is excited to welcome Lauxera to our committed group of shareholders and to our Board of Directors, […]

FluoGuide has received an award from The Association of Listed Danish Growth Companies in the category of “Largest Stock Price Increase Since IPO”. “We are very pleased by the recognition of our achievements since the IPO and our continuous commitment to improving outcomes for cancer patients,” says Morten Albrechtsen, CEO of FluoGuide. “The data we have […]

Elicera Therapeutics has received a Notice of Allowance from the Chinease Patent Office in its patent application relating to the use of the iTANK-technology in CAR T-cell therapies. Once granted, the patent can be kept in force until 2036. “iTANK is one of our key assets and together with the recently approved European patent we now […]